Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 5 (2008), Issue 12 (December)

1. C677T methylenetetrahydrofolate reductase gene polymorphisms in bipolar disorder: an association study in the Chinese population and a meta-analysis of genetic association studies.
   Neurosci Lett, 449(1): 48-51. [Abstract] [Full-text]
2. Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease.
   Prostaglandins Leukot Essent Fatty Acids, 79(3): 153-6. [Abstract] [Full-text]
3. Comorbidity of Asperger's syndrome and Bipolar disorder.
   Clin Pract Epidemol Ment Health, 4: 26. [Abstract] [Full-text]
4. Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial.
   Br J Psychiatry, 193(6): 477-84. [Abstract] [Full-text]
5. Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
   Expert Opin Pharmacother, 9(18): 3145-9. [Abstract] [Full-text]
6. The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder.
   Am J Psychiatry, 165(12): 1559-65. [Abstract] [Full-text]
7. Mental health of college students and their non-college-attending peers: results from the National Epidemiologic Study on Alcohol and Related Conditions.
   Arch Gen Psychiatry, 65(12): 1429-37. [Abstract] [Full-text]
8. Agomelatine treatment of major depressive disorder.
   Ann Pharmacother, 42(12): 1822-31. [Abstract] [Full-text]
9. The safety of the electroconvulsive therapy-escitalopram combination.
   J ECT, 24(4): 289-91. [Abstract] [Full-text]
10. The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study.
    BMC Emerg Med, 8(1): 17. [Abstract] [Full-text]
11. A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder.
    Neurosci Lett, 445(2): 184-7. [Abstract] [Full-text]
12. Impaired frontal synchronization of spontaneous magnetoencephalographic activity in patients with bipolar disorder.
    Neurosci Lett, 445(2): 174-8. [Abstract] [Full-text]
13. Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals.
    Drug Alcohol Depend, 99(1): 193-203. [Abstract] [Full-text]
14. Chinese version of the Delirium Rating Scale-Revised-98: reliability and validity.
    Compr Psychiatry, 50(1): 81-5. [Abstract] [Full-text]
15. Clinical characteristics influencing age at onset in psychotic disorders.
    Compr Psychiatry, 50(1): 13-9. [Abstract] [Full-text]
16. Clinical significance of lifetime panic disorder in the course of bipolar disorder type I.
    Compr Psychiatry, 50(1): 9-12. [Abstract] [Full-text]
17. Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project.
    Compr Psychiatry, 50(1): 1-8. [Abstract] [Full-text]
18. Safety monitoring of patients on atypical antipsychotics.
    Qual Saf Health Care, 17(6): 469-72. [Abstract] [Full-text]
19. Fronto-limbic circuitry in euthymic bipolar disorder: evidence for prefrontal hyperactivation.
    Psychiatry Res, 164(2): 106-13. [Abstract] [Full-text]
20. Comparisons of insight in schizophrenia, bipolar I disorder, and depressive disorders with and without comorbid alcohol use disorder.
    Psychiatry Clin Neurosci, 62(6): 685-90. [Abstract] [Full-text]
21. Prevalence, correlates, and disease patterns of antipsychotic use in Taiwan.
    Psychiatry Clin Neurosci, 62(6): 677-84. [Abstract] [Full-text]
22. Analysis during sinus rhythm and ventricular pacing of reentry circuit isthmus sites in right ventricular cardiomyopathy.
    Pacing Clin Electrophysiol, 31(12): 1535-45. [Abstract] [Full-text]
23. Quality of reporting controlled clinical trials on treatment of the acute mania phase of bipolar disorder with new antipsychotic drugs.
    Pharmacopsychiatry, 41(6): 240-1. [Abstract] [Full-text]
24. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.
    Cancer Lett, 273(2): 194-200. [Abstract] [Full-text]
25. Target identification for CNS diseases by transcriptional profiling.
    Neuropsychopharmacology, 34(1): 18-54. [Abstract] [Full-text]
26. The clinical-familial correlates and naturalistic outcome of panic-disorder-agoraphobia with and without lifetime bipolar II comorbidity.
    Ann Gen Psychiatry, 7: 23. [Abstract] [Full-text]
27. Is norepinephrine an etiological factor in some types of cancer?
    Int J Cancer, 124(2): 257-63. [Abstract] [Full-text]
28. Ian: a 7-year old with prenatal drug exposure and early exposure to family violence.
    J Dev Behav Pediatr, 29(6): 512-5. [Abstract] [Full-text]
29. The longitudinal course of comorbid oppositional defiant disorder in girls with attention-deficit/hyperactivity disorder: findings from a controlled 5-year prospective longitudinal follow-up study.
    J Dev Behav Pediatr, 29(6): 501-7. [Abstract] [Full-text]
30. Investigation of G72 (DAOA) expression in the human brain.
    BMC Psychiatry, 8(1): 94. [Abstract] [Full-text]
31. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Aust N Z J Psychiatry, 43(1): 53-60. [Abstract] [Full-text]
32. The clinical content of preconception care: women with psychiatric conditions.
    Am J Obstet Gynecol, 199(6): S328-32. [Abstract] [Full-text]
33. Inhibition and attention in adolescents with nonmanic mood disorders and a high risk for developing mania.
    J Clin Exp Neuropsychol, 31(1): 1-7. [Abstract] [Full-text]
34. Does hypomania distinguish bipolar II disorder from major depressive disorder?
    Psychother Psychosom, 78(1): 55-8. [Abstract] [Full-text]
35. Diacylglycerol kinase beta accumulates on the perisynaptic site of medium spiny neurons in the striatum.
    Eur J Neurosci, 28(12): 2409-22. [Abstract] [Full-text]
36. Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder.
    Int J Neuropsychopharmacol, 12(1): 33-43. [Abstract] [Full-text]
37. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
    Mol Psychiatry, 14(1): 51-9. [Abstract] [Full-text]
38. Functional analysis of a potassium-chloride co-transporter 3 (SLC12A6) promoter polymorphism leading to an additional DNA methylation site.
    Neuropsychopharmacology, 34(2): 458-67. [Abstract] [Full-text]
39. A framework for interpreting genome-wide association studies of psychiatric disorders.
    Mol Psychiatry, 14(1): 10-7. [Abstract] [Full-text]
40. Lower orbital frontal white matter integrity in adolescents with bipolar I disorder.
    J Am Acad Child Adolesc Psychiatry, 48(1): 79-86. [Abstract] [Full-text]
41. Lithium and hematology: established and proposed uses.
    J Leukoc Biol, 85(1): 20-8. [Abstract] [Full-text]
42. Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients.
    Psychiatry Res, 165(1): 193-6. [Abstract] [Full-text]
43. The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder.
    Psychiatry Res, 165(1): 163-74. [Abstract] [Full-text]
44. Assessment and treatment of suicide risk in bipolar disorders.
    Expert Rev Neurother, 9(1): 109-36. [Abstract] [Full-text]
45. GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability.
    Expert Rev Neurother, 9(1): 87-98. [Abstract] [Full-text]
46. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Expert Rev Neurother, 9(1): 9-31. [Abstract] [Full-text]
47. Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex.
    J Child Adolesc Psychopharmacol, 18(6): 623-7. [Abstract] [Full-text]
48. A pilot pharmacotherapy trial for depressed youths at high genetic risk for bipolarity.
    J Child Adolesc Psychopharmacol, 18(6): 615-21. [Abstract] [Full-text]
49. A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder.
    J Child Adolesc Psychopharmacol, 18(6): 595-605. [Abstract] [Full-text]
50. Temperament in child offspring of parents with bipolar disorder.
    J Child Adolesc Psychopharmacol, 18(6): 589-93. [Abstract] [Full-text]
51. Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders.
    J Child Adolesc Psychopharmacol, 18(6): 557-63. [Abstract] [Full-text]
52. Reduced gray matter volume in ventral prefrontal cortex but not amygdala in bipolar disorder: significant effects of gender and trait anxiety.
    Psychiatry Res, 171(1): 54-68. [Abstract] [Full-text]
53. Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study.
    Am J Geriatr Psychiatry, 17(1): 13-23. [Abstract] [Full-text]
54. Substance use disorders and suicide attempts in bipolar subtypes.
    J Psychiatr Res, 43(3): 230-8. [Abstract] [Full-text]
55. Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder.
    J Psychiatr Res, 43(3): 181-8. [Abstract] [Full-text]
56. Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials.
    Hum Psychopharmacol, 24(1): 19-28. [Abstract] [Full-text]
57. Serum creatine kinase activity differentiates alcohol syndromes of dependence, withdrawal and delirium tremens.
    Eur Neuropsychopharmacol, 19(2): 92-6. [Abstract] [Full-text]
58. Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania.
    J Neurosci Methods, 177(1): 44-50. [Abstract] [Full-text]
59. Substance use disorders as risk factors for psychiatric hospitalization in bipolar disorder.
    Psychiatr Serv, 60(1): 50-5. [Abstract] [Full-text]
60. The quality of asthma care among adults with substance-related disorders and adults with mental illness.
    Psychiatr Serv, 60(1): 43-9. [Abstract] [Full-text]
61. Glycogen synthase kinase-3 inhibition by 3-anilino-4-phenylmaleimides: insights from 3D-QSAR and docking.
    J Comput Aided Mol Des, 23(2): 113-27. [Abstract] [Full-text]
62. Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars.
    Proc Natl Acad Sci U S A, 105(52): 20935-40. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.